Literature DB >> 14980735

Release of [(3)H]-L-glutamate by stimulation of nicotinic acetylcholine receptors in rat cerebellar slices.

L A C Reno1, W Zago, R P Markus.   

Abstract

This is a neurochemical study which shows that nicotine acting through alpha7-containing nicotinic acetylcholine receptors promotes the release of [(3)H]-glutamate from rat cerebellar slices. Release evoked by half maximal concentration of nicotine (100 microM) was blocked by alpha-bungarotoxin and in a calcium-free medium, suggesting an effect mediated by an alpha7 receptor. Dihydro-beta-erythroidine and mecamylamine were effective only at very high concentrations, excluding the participation of heteromeric receptors. The effect of nicotine was partially blocked by inhibitors of glutamatergic receptors DL-2-amino-5-phosphonovaleric acid and 6-cyano-7-nitroquinoxaline-2,3-dione, indicating a glutamate-induced glutamate release. Nicotine-evoked response was dependent on activation of tetrodotoxin sensitive sodium channels. Therefore, here we show that glutamate released by stimulation of alpha7-containing nicotinic receptors, located preterminal and/or postsynaptically, evokes a further glutamate release in adult rat cerebellar slices.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980735     DOI: 10.1016/j.neuroscience.2003.12.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

Review 1.  Prefrontal neuromodulation by nicotinic receptors for cognitive processes.

Authors:  Renata dos Santos Coura; Sylvie Granon
Journal:  Psychopharmacology (Berl)       Date:  2012-01-18       Impact factor: 4.530

2.  Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470.

Authors:  Nathalie Gérard; Jenny Ceccarini; Guy Bormans; Bert Vanbilloen; Cindy Casteels; Karolien Goffin; Barbara Bosier; Didier M Lambert; Koen Van Laere
Journal:  J Mol Neurosci       Date:  2010-02-25       Impact factor: 3.444

3.  Ethanol-Induced Cerebellar Ataxia: Cellular and Molecular Mechanisms.

Authors:  M Saeed Dar
Journal:  Cerebellum       Date:  2015-08       Impact factor: 3.847

4.  Additive interaction between scopolamine and nitric oxide agents on immobility in the forced swim test but not exploratory activity in the hole-board.

Authors:  Mohammad Nasehi; Mohammad-Hossein Mohammadi-Mahdiabadi-Hasani; Mohaddeseh Ebrahimi-Ghiri; Mohammad-Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2019-06-07       Impact factor: 4.530

5.  Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats.

Authors:  Sherin Antony; T Peeyush Kumar; Jobin Mathew; T R Anju; C S Paulose
Journal:  J Biomed Sci       Date:  2010-02-05       Impact factor: 8.410

Review 6.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

7.  Gating of long-term potentiation by nicotinic acetylcholine receptors at the cerebellum input stage.

Authors:  Francesca Prestori; Claudia Bonardi; Lisa Mapelli; Paola Lombardo; Rianne Goselink; Maria Egle De Stefano; Daniela Gandolfi; Jonathan Mapelli; Daniel Bertrand; Martijn Schonewille; Chris De Zeeuw; Egidio D'Angelo
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes.

Authors:  Jill R Turner; Kenneth J Kellar
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

9.  Enhancement in motor learning through genetic manipulation of the Lynx1 gene.

Authors:  Julie M Miwa; Andreas Walz
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Ischemia induces release of endogenous amino acids from the cerebral cortex and cerebellum of developing and adult mice.

Authors:  Simo S Oja; Pirjo Saransaari
Journal:  J Amino Acids       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.